A novel GLP1 receptor interacting protein ATP6ap2 regulates insulin secretion in pancreatic beta cells

Journal of Biological Chemistry

Volumn 290, Issue 41, 2015, Pages 25045-25061

  Dai, Feihan F ^a   Bhattacharjee, Alpana ^a   Liu, Ying ^a   Batchuluun, Battsetseg ^a   Zhang, Ming ^a   Wang, Xinye Serena ^a   Huang, Xinyi ^a   Luu, Lemieux ^a   Zhu, Dan ^a   Gaisano, Herbert ^a   Wheeler, Michael B ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDIFICATION; CELL SIGNALING; CELLS; CYTOLOGY; GRANULATION; MAMMALS; PHYSIOLOGY; PROTEINS;

CO-IMMUNOPRECIPITATIONS; INSULIN GRANULES; INSULIN SECRETION; MEMBRANE-BASED; OVER-EXPRESSION; PANCREATIC BETA CELLS; RECEPTOR-INTERACTING PROTEINS; YEAST TWO-HYBRID ASSAYS;

INSULIN;

CALCIUM ION; CELL RECEPTOR; CYCLIC AMP; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOSE; RENIN RECEPTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ATP6AP2 PROTEIN, HUMAN; ATP6AP2 PROTEIN, MOUSE; CALCIUM; CELL SURFACE RECEPTOR; INSULIN; PROTEIN BINDING; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

ACIDIFICATION; ARTICLE; CALCIUM TRANSPORT; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA LIBRARY; HUMAN; INSULIN RELEASE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SUBUNIT; REGULATORY MECHANISM; TWO HYBRID SYSTEM; ANIMAL; CHO CELL LINE; CRICETULUS; DEFICIENCY; DRUG EFFECTS; GENE SILENCING; GENETICS; HAMSTER; METABOLISM; SECRETION (PROCESS); TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CALCIUM; CHO CELLS; CRICETINAE; CRICETULUS; CYCLIC AMP; GENE KNOCKDOWN TECHNIQUES; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MALE; MICE; PROTEIN BINDING; PROTON-TRANSLOCATING ATPASES; RECEPTORS, CELL SURFACE; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 84943742313     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.648592     Document Type: Article

References (67)

1. Drucker, D. J., and Nauck, M. A. (2006) The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368, 1696-1705
2. Edwards, C. M., Todd, J. F., Mahmoudi, M., Wang, Z., Wang, R. M., Ghatei, M. A., and Bloom, S. R. (1999) Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39. Diabetes 48, 86-93
3. Kreymann, B., Williams, G., Ghatei, M. A., and Bloom, S. R. (1987) Glucagonlike peptide-1 7-36: a physiological incretin in man. Lancet 2, 1300-1304
4. Salehi, M., Vahl, T. P., and D'Alessio, D. A. (2008) Regulation of islet hormone release and gastric emptying by endogenous glucagon-like peptide 1 after glucose ingestion. J. Clin. Endocrinol. Metab. 93, 4909-4916
5. Woerle, H. J., Carneiro, L., Derani, A., Göke, B., and Schirra, J. (2012) The role of endogenous incretin secretion as amplifier of glucose-stimulated insulin secretion in healthy subjects and patients with type 2 diabetes. Diabetes 61, 2349-2358
6. Boutant, M., Ramos, O. H., Tourrel-Cuzin, C., Movassat, J., Ilias, A., Vallois, D., Planchais, J., Pégorier, J. P., Schuit, F., Petit, P. X., Bossard, P., Maedler, K., Grapin-Botton, A., and Vasseur-Cognet, M. (2012) COUPTFII controls mouse pancreatic β-cell mass through GLP-1-β-catenin signaling pathways. PLoS One 7, e30847
7. Heller, C., Kühn, M. C., Mülders-Opgenoorth, B., Schott, M., Willenberg, H. S., Scherbaum, W. A., and Schinner, S. (2011) Exendin-4 upregulates the expression of Wnt-4, a novel regulator of pancreatic β-cell proliferation. Am. J. Physiol. Endocrinol. Metab. 301, E864-E872
8. Liu, Z., and Habener, J. F. (2008) Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic β cell proliferation. J. Biol. Chem. 283, 8723-8735
9. Ye, Y., Keyes, K. T., Zhang, C., Perez-Polo, J. R., Lin, Y., and Birnbaum, Y. (2010) The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA. Am. J. Physiol. Heart Circ. Physiol. 298, H1454-H1465
10. Sokos, G. G., Nikolaidis, L. A., Mankad, S., Elahi, D., and Shannon, R. P. (2006) Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure. J. Card. Fail. 12, 694-699
11. Krisai, P., Aeschbacher, S., Schoen, T., Bossard, M., van der Stouwe, J. G., Dörig, L., Todd, J., Estis, J., Risch, M., Risch, L., and Conen, D. (2015) Glucagon-like peptide-1 and blood pressure in young and healthy adults from the general population. Hypertension 65, 306-312
12. Hirata, K., Kume, S., Araki, S., Sakaguchi, M., Chin-Kanasaki, M., Isshiki, K., Sugimoto, T., Nishiyama, A., Koya, D., Haneda, M., Kashiwagi, A., and Uzu, T. (2009) Exendin-4 has an anti-hypertensive effect in salt-sensitive mice model. Biochem. Biophys. Res. Commun. 380, 44-49
13. von Scholten, B. J., Lajer, M., Goetze, J. P., Persson, F., and Rossing, P. (2015) Time course and mechanisms of the anti-hypertensive and renal effects of liraglutide treatment. Diabet. Med. 32, 343-352
14. Yu, M., Moreno, C., Hoagland, K. M., Dahly, A., Ditter, K., Mistry, M., and Roman, R. J. (2003) Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats. J. Hypertens. 21, 1125-1135
15. During, M. J., Cao, L., Zuzga, D. S., Francis, J. S., Fitzsimons, H. L., Jiao, X., Bland, R. J., Klugmann, M., Banks, W. A., Drucker, D. J., and Haile, C. N. (2003) Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat. Med. 9, 1173-1179
16. Hamilton, A., Patterson, S., Porter, D., Gault, V. A., and Holscher, C. (2011) Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain. J. Neurosci. Res. 89, 481-489
17. Hunter, K., and Hölscher, C. (2012) Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis. BMC Neurosci. 13, 33
18. Dillon, J. S., Tanizawa, Y., Wheeler, M. B., Leng, X. H., Ligon, B. B., Rabin, D. U., Yoo-Warren, H., Permutt, M. A., and Boyd, A. E., 3rd (1993) Cloning and functional expression of the human glucagon-like peptide-1 (GLP-1) receptor. Endocrinology 133, 1907-1910
19. Jun, L. S., Showalter, A. D., Ali, N., Dai, F., Ma, W., Coskun, T., Ficorilli, J. V., Wheeler, M. B., Michael, M. D., and Sloop, K. W. (2014) A novel humanized GLP-1 receptor model enables both affinity purification and Cre-LoxP deletion of the receptor. PLoS. One 9, e93746
20. Pyke, C., Heller, R. S., Kirk, R. K., Ørskov, C., Reedtz-Runge, S., Kaastrup, P., Hvelplund, A., Bardram, L., Calatayud, D., and Knudsen, L. B. (2014) GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody. Endocrinology 155, 1280-1290
21. Richards, P., Parker, H. E., Adriaenssens, A. E., Hodgson, J. M., Cork, S. C., Trapp, S., Gribble, F. M., and Reimann, F. (2014) Identification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model. Diabetes 63, 1224-1233
22. Gromada, J., Holst, J. J., and Rorsman, P. (1998) Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1. Pflugers Arch. 435, 583-594
23. Wheeler, M. B., Lu, M., Dillon, J. S., Leng, X. H., Chen, C., and Boyd, A. E. III (1993) Functional expression of the rat glucagon-like peptide-I receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C. Endocrinology 133, 57-62
24. Seino, S., and Shibasaki, T. (2005) PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis. Physiol. Rev. 85, 1303-1342
25. Gromada, J., Bokvist, K., Ding, W. G., Holst, J. J., Nielsen, J. H., and Rorsman, P. (1998) Glucagon-like peptide 1 (7-36) amide stimulates exocytosis in human pancreatic β-cells by both proximal and distal regulatory steps in stimulus-secretion coupling. Diabetes 47, 57-65
26. 2+ release in INS-1 pancreatic β-cells. J. Physiol. 536, 375-385
27. Buteau, J., Foisy, S., Rhodes, C. J., Carpenter, L., Biden, T. J., and Prentki, M. (2001) Protein kinase Czeta activation mediates glucagon-like peptide-1-induced pancreatic β-cell proliferation. Diabetes 50, 2237-2243
28. Buteau, J., Foisy, S., Joly, E., and Prentki, M. (2003) Glucagon-like peptide 1 induces pancreatic β-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes 52, 124-132
29. Bockaert, J., Fagni, L., Dumuis, A., and Marin, P. (2004) GPCR interacting proteins (GIP). Pharmacol. Ther. 103, 203-221
30. Schwenk, J., Metz, M., Zolles, G., Turecek, R., Fritzius, T., Bildl, W., Tarusawa, E., Kulik, A., Unger, A., Ivankova, K., Seddik, R., Tiao, J. Y., Rajalu, M., Trojanova, J., Rohde, V., Gassmann, M., Schulte, U., Fakler, B., and Bettler, B. (2010) Native GABAB receptors are heteromultimers with a family of auxiliary subunits. Nature 465, 231-235
31. Sonoda, N., Imamura, T., Yoshizaki, T., Babendure, J. L., Lu, J. C., and Olefsky, J. M. (2008) β-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic β cells. Proc. Natl. Acad. Sci. U. S. A. 105, 6614-6619
32. Syme, C. A., Zhang, L., and Bisello, A. (2006) Caveolin-1 regulates cellular trafficking and function of the glucagon-like peptide 1 receptor. Mol. Endocrinol. 20, 3400-3411
33. Talbot, J., Joly, E., Prentki, M., and Buteau, J. (2012) β-Arrestin1-mediated recruitment of c-Src underlies the proliferative action of glucagon-like peptide-1 in pancreatic β INS832/13 cells. Mol. Cell Endocrinol. 364, 65-70
34. Huang, X., Dai, F. F., Gaisano, G., Giglou, K., Han, J., Zhang, M., Kittanakom, S., Wong, V., Wei, L., Showalter, A. D., Sloop, K. W., Stagljar, I., and Wheeler, M. B. (2013) The identification of novel proteins that interact with the GLP-1 receptor and restrain its activity. Mol. Endocrinol. 27, 1550-1563
35. Joseph, J. W., Koshkin, V., Saleh, M. C., Sivitz, W. I., Zhang, C. Y., Lowell, B. B., Chan, C. B., and Wheeler, M. B. (2004) Free fatty acid-induced β-cell defects are dependent on uncoupling protein 2 expression. J. Biol. Chem. 279, 51049-51056
36. Liu, Y., Batchuluun, B., Ho, L., Zhu, D., Prentice, K. J., Bhattacharjee, A., Zhang, M., Pourasgari, F., Hardy, A. B., Taylor, K. M., Gaisano, H., Dai, F. F., and Wheeler, M. B. (2015) Characterization of zinc influx transporters (ZIPs) in pancreatic β cells: roles in regulating cytosolic zinc homeostasis and insulin secretion. J. Biol. Chem. 290, 18757-18769
37. Wolff, N. A., Ghio, A. J., Garrick, L. M., Garrick, M. D., Zhao, L., Fenton, R. A., and Thévenod, F. (2014) Evidence for mitochondrial localization of divalent metal transporter 1 (DMT1). FASEB J. 28, 2134-2145
38. Dünnwald, M., Varshavsky, A., and Johnsson, N. (1999) Detection of transient in vivo interactions between substrate and transporter during protein translocation into the endoplasmic reticulum. Mol. Biol. Cell 10, 329-344
39. Johnsson, N., and Varshavsky, A. (1994) Ubiquitin-assisted dissection of protein transport across membranes. EMBO J. 13, 2686-2698
40. Stagljar, I., Korostensky, C., Johnsson, N., and te Heesen, S. (1998) A genetic system based on split-ubiquitin for the analysis of interactions between membrane proteins in vivo. Proc. Natl. Acad. Sci. U. S. A. 95, 5187-5192
41. Wittke, S., Lewke, N., Müller, S., and Johnsson, N. (1999) Probing the molecular environment of membrane proteins in vivo. Mol. Biol. Cell 10, 2519-2530
42. 2+ sensor protein visinin-like protein-1 is expressed in pancreatic islets and regulates insulin secretion. J. Biol. Chem. 281, 21942-21953
43. Zhang, M., Robitaille, M., Showalter, A. D., Huang, X., Liu, Y., Bhattacharjee, A., Willard, F. S., Han, J., Froese, S., Wei, L., Gaisano, H. Y., Angers, S., Sloop, K. W., Dai, F. F., and Wheeler, M. B. (2014) Progesterone receptor membrane component 1 is a functional part of the glucagon-like peptide-1 (GLP-1) receptor complex in pancreatic β cells. Mol. Cell Proteomics 13, 3049-3062
44. Wijesekara, N., Dai, F. F., Hardy, A. B., Giglou, P. R., Bhattacharjee, A., Koshkin, V., Chimienti, F., Gaisano, H. Y., Rutter, G. A., and Wheeler, M. B. (2010) β Cell-specific Znt8 deletion in mice causes marked defects in insulin processing, crystallisation and secretion. Diabetologia 53, 1656-1668
45. Lu, H., Koshkin, V., Allister, E. M., Gyulkhandanyan, A. V., and Wheeler, M. B. (2010) Molecular and metabolic evidence for mitochondrial defects associated with β-cell dysfunction in a mouse model of type 2 diabetes. Diabetes 59, 448-459
46. Wu, C., Orozco, C., Boyer, J., Leglise, M., Goodale, J., Batalov, S., Hodge, C. L., Haase, J., Janes, J., Huss, J. W., 3rd, and Su, A. I. (2009) BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol. 10, R130
47. Wu, C., Macleod, I., and Su, A. I. (2013) BioGPS and MyGene.info: organizing online, gene-centric information. Nucleic Acids Res. 41, D561-D565
48. Jansen, E. J., and Martens, G. J. (2012) Novel insights into V-ATPase functioning: distinct roles for its accessory subunits ATP6AP1/Ac45 and ATP6AP2/(pro) renin receptor. Curr. Protein Pept. Sci. 13, 124-133
49. Forgac, M. (2007) Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat. Rev. Mol. Cell Biol. 8, 917-929
50. Marshansky, V., and Futai, M. (2008) The V-type H β-ATPase in vesicular trafficking: targeting, regulation and function. Curr. Opin. Cell Biol. 20, 415-426
51. Smeekens, S. P., Montag, A. G., Thomas, G., Albiges-Rizo, C., Carroll, R., Benig, M., Phillips, L. A., Martin, S., Ohagi, S., and Gardner, P.,. (1992) Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3. Proc. Natl. Acad. Sci. U. S. A. 89, 8822-8826
52. Muller, L., and Lindberg, I. (1999) The cell biology of the prohormone convertases PC1 and PC2. Prog. Nucleic Acids Res. Mol. Biol. 63, 69-108
53. Naggert, J. K., Fricker, L. D., Varlamov, O., Nishina, P. M., Rouille, Y., Steiner, D. F., Carroll, R. J., Paigen, B. J., and Leiter, E. H. (1995) Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat. Genet. 10, 135-142
54. Seidah, N. G., Mowla, S. J., Hamelin, J., Mamarbachi, A. M., Benjannet, S., Touré, B. B., Basak, A., Munzer, J. S., Marcinkiewicz, J., Zhong, M., Barale, J. C., Lazure, C., Murphy, R. A., Chrétien, M., and Marcinkiewicz, M. (1999) Mammalian subtilisin/kexin isozyme SKI-1: A widely expressed proprotein convertase with a unique cleavage specificity and cellular localization. Proc. Natl. Acad. Sci. U. S. A. 96, 1321-1326
55. Zhu, X., Orci, L., Carroll, R., Norrbom, C., Ravazzola, M., and Steiner, D. F. (2002) Severe block in processing of proinsulin to insulin accompanied by elevation of des-64, 65 proinsulin intermediates in islets of mice lacking prohormone convertase 1/3. Proc. Natl. Acad. Sci. U. S. A. 99, 10299-10304
56. Rorsman, P., Eliasson, L., Renström, E., Gromada, J., Barg, S., and Göpel, S. (2000) The cell physiology of biphasic insulin secretion. News Physiol. Sci. 15, 72-77
57. Sun-Wada, G. H., Toyomura, T., Murata, Y., Yamamoto, A., Futai, M., and Wada, Y. (2006) The a3 isoform of V-ATPase regulates insulin secretion from pancreatic β-cells. J. Cell Sci. 119, 4531-4540
58. 2+ and stimulates mitochondrial ATP synthesis in pancreatic MIN6 β-cells. Biochem. J. 369, 287-299
59. Ludwig, J., Kerscher, S., Brandt, U., Pfeiffer, K., Getlawi, F., Apps, D. K., and Schägger, H. (1998) Identification and characterization of a novel 9.2-kDa membrane sector-associated protein of vacuolar proton-ATPase from chromaffin granules. J. Biol. Chem. 273, 10939-10947
60. +-ATPase-mediated acidification for Wnt signaling. Science 327, 459-463
61. Gunton, J. E., Kulkarni, R. N., Yim, S., Okada, T., Hawthorne, W. J., Tseng, Y. H., Roberson, R. S., Ricordi, C., O'Connell, P. J., Gonzalez, F. J., and Kahn, C. R. (2005) Loss of ARNT/HIF1β mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 122, 337-349
62. Riediger, F., Quack, I., Qadri, F., Hartleben, B., Park, J. K., Potthoff, S. A., Sohn, D., Sihn, G., Rousselle, A., Fokuhl, V., Maschke, U., Purfürst, B., Schneider, W., Rump, L. C., Luft, F. C., Dechend, R., Bader, M., Huber, T. B., Nguyen, G., and Muller, D. N. (2011) Prorenin receptor is essential for podocyte autophagy and survival. J. Am. Soc. Nephrol. 12, 2193-2202
63. Sihn, G., Rousselle, A., Vilianovitch, L., Burckle, C., and Bader, M. (2010) Physiology of the (pro) renin receptor: Wnt of change? Kidney Int. 78, 246-256
64. +-ATPase assembly in murine cardiomyocytes. Circ. Res. 107, 30-34
65. Oshima, Y., Kinouchi, K., Ichihara, A., Sakoda, M., Kurauchi-Mito, A., Bokuda, K., Narita, T., Kurosawa, H., Sun-Wada, G. H., Wada, Y., Yamada, T., Takemoto, M., Saleem, M. A., Quaggin, S. E., and Itoh, H. (2011) Prorenin receptor is essential for normal podocyte structure and function. J. Am. Soc. Nephrol. 22, 2203-2212
66. Davidson, H., Rhodes, C. J., Hutton, J. C. (1988) Intraorganellar calcium and pH control proinsulin cleavage in the pancreatic β-cell via two distinct site-specific endopeptidases. Nature 333, 93-96
67. Orci, L., Halban, P., Perrelet, A., Amherdt, M., Ravazzola, M., and Anderson, R. G. (1994) pH-independent and -dependent cleavage of proinsulin in the same secretory vesicle. J. Cell Biol. 126, 1149-1156